Balyasny Asset Management LLC Pfizer Inc Put Options Transaction History

Balyasny Asset Management LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $2.83 Million - $3.25 Million	-109,200 Reduced 11.33%	854,700 $23.7 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $4.71 Million - $6.12 Million	-180,400 Reduced 15.77%	963,900 $27.8 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $940,237 - $1.1 Million	29,300 Added 2.63%	1,144,300 $38 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $28.7 Million - $33.3 Million	795,900 Added 249.42%	1,115,000 $40.9 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $4.92 Million - $6.41 Million	-125,000 Reduced 28.15%	319,100 $13 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $797,425 - $1.04 Million	19,100 Added 4.49%	444,100 $22.8 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $109 Million - $134 Million	-2,501,000 Reduced 85.48%	425,000 $18.6 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $112 Million - $132 Million	2,400,000 Added 456.27%	2,926,000 $153 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $21.8 Million - $27 Million	476,000 Added 952.0%	526,000 $27.2 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $36.4 Million - $54 Million	-881,600 Reduced 94.63%	50,000 $2.95 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $19.4 Million - $22 Million	541,600 Added 138.87%	931,600 $36.5 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $9.38 Million - $10.6 Million	280,000 Added 254.55%	390,000 $14.1 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $3.68 Million - $4.68 Million	110,000 New	110,000 $4.05 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.